Methods for preserving the viability of retinal ganglion cells in patients with glaucoma by an anti-TNF receptor 2 (anti-TNFR2) antibody

• 收藏
• 分享

专利权人:

发明人:

Toru Nakazawa

申请号：

US14812566

公开号：

US09914782B2

申请日:

2015.07.29

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention provides a method of preserving ocular cells in a patient having or at risk of developing glaucoma. In particular, microglial cell activation can be decreased, oligodendrocyte loss can be reduced, and/or the viability of retinal ganglion cells can be preserved by administering a selective TNFR2 antagonist to an individual having or at risk of developing glaucoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/